Literature DB >> 28739744

Overexpression of EPHB4 Is Associated with Poor Survival of Patients with Gastric Cancer.

Jie Yin1,2,3, Yuxin Cui1, Liting Li1,4, Jiafu Ji4, Wen G Jiang5.   

Abstract

BACKGROUND: Increased expression of erythropoietin-producing human hepatoma (EPHB4) leads to enhanced cell migration, growth and adhesion in tumor cells. However, little is known regarding the effects of EPHB4 in gastric cancer. The present study aimed to examine the clinical relevance of EPHB4 and its association with the prognosis of gastric cancer.
MATERIALS AND METHODS: EPHB4 transcript expression in 324 gastric cancer samples with paired adjacent normal gastric tissues was determined using quantitative polymerase chain reaction and the results were statistically analyzed against patient clinicopathological data. AGS and HGC27 cell lines were transfected with EPHB4 siRNA and the effects examined by functional analysis.
RESULTS: EPHB4 mRNA levels in gastric cancer tissues were significantly elevated when compared to non-cancerous tissues (p=0.0110). Tissue samples from male patients exhibited lower expression than those from female patients (p=0.0110). Non-cardiac gastric tumors (fundus, corpus and pylorus) expressed a higher number of EPHB4 transcripts in comparison to cardiac gastric tumors (p<0.001). Increased expression of EPHB4 was significantly associated with poorer overall (p=0.0051) and progression-free (p=0.0262) survival. EPHB4 knockdown appeared to reduce post-wound migration of AGS cells (p=0.0057) and increase migration of HGC27 cells (p=0.0337). EPHB4 knockdown significantly increased adhesive ability in HGC27 (p<0.0001).
CONCLUSION: The expression of EPHB4 was increased in gastric cancer and increased EPHB4 expression was correlated with poor survival. Knockdown of EPHB4 promoted adhesion and exerted diverse effects on migration of gastric cancer cells. Further investigations may highlight its predictive and therapeutic potential in gastric cancer. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  EPHB4; gastric cancer; survival

Mesh:

Substances:

Year:  2017        PMID: 28739744     DOI: 10.21873/anticanres.11845

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  A gene expression-based risk model reveals prognosis of gastric cancer.

Authors:  Xiaorong Deng; Qun Xiao; Feng Liu; Cihua Zheng
Journal:  PeerJ       Date:  2018-01-02       Impact factor: 2.984

2.  Characterization of an orthotopic gastric cancer mouse model with lymph node and organ metastases using bioluminescence imaging.

Authors:  Hai-Yi Feng; Yunpeng Zhang; Hai-Jun Liu; Xiao Dong; Si-Cong Yang; Qin Lu; Fanping Meng; Hong-Zhuan Chen; Peng Sun; Chao Fang
Journal:  Oncol Lett       Date:  2018-08-16       Impact factor: 2.967

3.  Expression levels of EPHB4, EFNB2 and caspase-8 are associated with clinicopathological features and progression of esophageal squamous cell cancer.

Authors:  Qianzhi Ni; Pingping Chen; Bing Zhu; Jingjing Li; Dong Xie; Xingyuan Ma
Journal:  Oncol Lett       Date:  2019-11-28       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.